Peking University Third Hospital has officially introduced palopegteriparatide, the world’s first and only approved parathyroid...
MindRank, a clinical-stage AI-native drug discovery company, announced the completion of a $52 million Series...
Shanghai Stexo Biotechnology Co., Ltd. announced that its proprietary extracellular vesicle drug STX11101 injection, derived...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA: 688796, HKG: 2315) and Whitehawk Therapeutics, Inc. (NASDAQ: WHWK)...
Sino Biopharmaceutical Limited (HKG: 1177) announced an expanded strategic partnership with GlaxoSmithKline plc (GSK, NYSE:...
China’s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and...
China’s National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) unveiled the “PIONEER” (Propel...
Immunocon and MabGalaxy announced a comprehensive upgrade of their strategic cooperation, integrating artificial intelligence and...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) announced a definitive acquisition...
Hainan Shuangcheng Pharmaceutical Co., Ltd. (SHE: 002693) announced an exclusive licensing agreement with undisclosed American...
CStone Pharmaceuticals (HKG: 2616) announced an exclusive commercialization partnership with Arrotex Pharmaceuticals Pty Ltd, the...
Serapha Bio announced a transformative series of transactions including an exclusive worldwide license from YolTech...
Alphamab Oncology (HKG: 9966) announced a strategic cooperation agreement with Russian biopharmaceutical company LLC Nanolek,...
TrueLab Biopharmaceutical announced an exclusive license agreement with newly launched clinical-stage company Bionyra Pharma, granting...
Shanghai ZJ Bio-Tech Co., Ltd. (SHA: 688317) announced that its Ebola Virus Nucleic Acid Detection...
cAMPfield Therapeutics, Inc. announced its official launch alongside the completion of a $180 million Series...
BriSTAR Immunotech (Beijing) Co., Ltd. announced the completion of a Series C financing round exceeding...
Formosa Pharmaceuticals (TPE: 6838) announced an exclusive licensing agreement with South Korea’s Samil Pharmaceuticals, Co.,...
Jiangsu Carephar Pharmaceutical Co., Ltd. and Silk Road Medical Technology announced a strategic cooperation agreement...
The Guangdong Provincial Medical Products Administration, in collaboration with the Department of Industry and Information...